VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by fivenineron Nov 30, 2017 8:15am

90 Views

Post# 27061561

RE:VPT's MD & A looks really promising

One of the biggest warning signs of a stock that is going to tank is when forum posters get desperate and obviously over-value the positives and overlook the negatives.

TrendyWolf wrote: Sales efforts have begun, $3M in cash (really $2.27M - 75% of stated), and now debt free! Operating expenses a little high (operating expenses so high that VPT will burn through its cash in the next 4 months) but that's to be expected as they have now fully ramped up the sales efforts, hiring, etc. Looks good heading into Dec and the New Year!!

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading